Thousands of kidney disease patients set to benefit from £1-a-dose diabetes drug which can reduce the need for dialysis and a transplant

Kidney disease is usually triggered by the damage caused by another illness, such as type 1 and type 2 diabetes or high blood pressure.

Related Keywords

United Kingdom ,Glasgow ,Glasgow City ,Aisling Mcmahon ,Angela Riley ,Kidney Research United Kingdom ,University Of Oxford ,National Institute For Health ,National Institute ,Care Excellence ,Will Herrington ,Medical Minefield ,Dailymail ,Health ,Diabetes ,